AAAAAA
Results:
1-19
|
Results: 19
Authors:
PETTIGREW LC
BIEBER F
LETTIERI J
WERMELING DP
FREDERICK D
SCHMITT A
TIKHTMAN AJ
ASHFORD JW
SMITH CD
WEKSTEIN DR
MARKESBERY WR
ORAZEM J
RUZICKA BB
MAS J
GULANSKI B
Citation: Lc. Pettigrew et al., PHARMACOKINETICS, PHARMACODYNAMICS, AND SAFETY OF METRIFONATE IN PATIENTS WITH ALZHEIMERS-DISEASE, Journal of clinical pharmacology, 38(3), 1998, pp. 236-245
Authors:
CUMMINGS JL
CYRUS PA
BIEBER F
MAS J
ORAZEM J
GULANSKI B
Citation: Jl. Cummings et al., METRIFONATE TREATMENT OF THE COGNITIVE DEFICITS OF ALZHEIMERS-DISEASE, Neurology, 50(5), 1998, pp. 1214-1221
Authors:
MORRIS JC
CYRUS PA
ORAZEM J
MAS J
BIEBER F
RUZICKA BB
GULANSKI B
Citation: Jc. Morris et al., METRIFONATE BENEFITS COGNITIVE, BEHAVIORAL, AND GLOBAL FUNCTION IN PATIENTS WITH ALZHEIMERS-DISEASE, Neurology, 50(5), 1998, pp. 1222-1230
Authors:
FARLOW MR
LAHIRI DK
BRASHEAR A
CYRUS PA
GULANSKI B
Citation: Mr. Farlow et al., METRIFONATE IN THE SYMPTOMATIC TREATMENT OF ALZHEIMERS-DISEASE - INFLUENCE OF APOLIPOPROTEIN-E GENOTYPE, Neurology, 50(4), 1998, pp. 2010-2010
Authors:
CYRUS PA
RUZICKA BB
GULANSKI B
Citation: Pa. Cyrus et al., THE DOSE-RELATED IMPROVEMENT BY METRIFONATE OF THE COGNITIVE PERFORMANCE OF ALZHEIMERS-DISEASE PATIENTS, Neurology, 50(4), 1998, pp. 2012-2012
Authors:
GELINAS I
GAUTHIER S
CYRUS PA
RUZICKA BB
GULANSKI B
Citation: I. Gelinas et al., THE EFFICACY OF METRIFONATE IN ENHANCING THE ABILITY OF ALZHEIMERS-DISEASE PATIENTS TO PERFORM BASIC AND INSTRUMENTAL ACTIVITIES OF DAILY LIVING, Neurology, 50(4), 1998, pp. 2018-2018
Authors:
CUMMINGS JL
CYRUS PA
RUZICKA BB
GULANSKI B
Citation: Jl. Cummings et al., THE EFFICACY OF METRIFONATE IN IMPROVING THE BEHAVIORAL DISTURBANCES OF ALZHEIMERS-DISEASE PATIENTS, Neurology, 50(4), 1998, pp. 24004-24004
Authors:
CUTLER NR
JHEE SS
CYRUS P
BIEBER F
TANPIENGCO P
SRAMEK JJ
GULANSKI B
Citation: Nr. Cutler et al., SAFETY AND TOLERABILITY OF METRIFONATE IN PATIENTS WITH ALZHEIMERS-DISEASE - RESULTS OF A MAXIMUM TOLERATED DOSE STUDY, Life sciences, 62(16), 1998, pp. 1433-1441
Authors:
CUTLER NR
CYRUS P
SRAMEK JJ
BIEBER F
TANPIENGCO P
GULANSKI B
Citation: Nr. Cutler et al., THE MAXIMUM TOLERATED DOSE (MTD) OF METRIFONATE IN ALZHEIMERS PATIENTS, Biological psychiatry, 43, 1998, pp. 156-156
Authors:
FARLOW MR
CYRUS PA
GULANSKI B
Citation: Mr. Farlow et al., METRIFONATE IMPROVES THE COGNITIVE-ABILITY OF ALZHEIMERS-DISEASE PATIENTS IN A DOSE-RELATED MANNER, Journal of the American Geriatrics Society, 46(9), 1998, pp. 15-15
Authors:
GAUTHIER S
GELINAS I
CYRUS PA
GULANSKI B
Citation: S. Gauthier et al., METRIOFONATE ENHANCES THE ABILITY OF ALZHEIMERS-DISEASE PATIENTS TO PERFORM INSTRUMENTAL AND BASIC ACTIVITY OF DAILY LIVING, Journal of the American Geriatrics Society, 46(9), 1998, pp. 73-73
Authors:
CYRUS PA
RUZICKA B
GULANSKI B
Citation: Pa. Cyrus et al., METRIFONATE IN THE LONG-TERM TREATMENT OF ALZHEIMERS-DISEASE, Journal of the American Geriatrics Society, 46(9), 1998, pp. 76-76
Authors:
CUMMINGS JL
CYRUS PA
GULANSKI B
Citation: Jl. Cummings et al., METRIFONATE EFFICACY IN THE TREATMENT OF PSYCHIATRIC AND BEHAVIORAL DISTURBANCES OF ALZHEIMERS-DISEASE PATIENTS, Journal of the American Geriatrics Society, 46(9), 1998, pp. 196-196
Authors:
DORAISWAMY PM
BIEBER F
KAISER L
GULANSKI B
Citation: Pm. Doraiswamy et al., THE ALZHEIMERS-DISEASE ASSESSMENT SCALE .6. NONCOGNITIVE SIGNS AND SYMPTOMS IN OUTPATIENTS WITH ALZHEIMERS-DISEASE, Psychopharmacology bulletin, 33(3), 1997, pp. 514-514
MEMORY, LANGUAGE, AND PRAXIS IN ALZHEIMERS-DISEASE - NORMS FOR OUTPATIENT CLINICAL-TRIAL POPULATIONS
Authors:
DORAISWAMY PM
BIEBER F
KAISER L
CONNORS K
KRISHNAN KR
REUNINGSCHERER J
GULANSKI B
Citation: Pm. Doraiswamy et al., MEMORY, LANGUAGE, AND PRAXIS IN ALZHEIMERS-DISEASE - NORMS FOR OUTPATIENT CLINICAL-TRIAL POPULATIONS, Psychopharmacology bulletin, 33(1), 1997, pp. 123-128
Authors:
MORRIS J
CYRUS P
ORAZEM J
MAS J
BIEBER F
GULANSKI B
Citation: J. Morris et al., METRIFONATE - POTENTIAL THERAPY FOR ALZHEIMERS-DISEASE, Neurology, 48(6), 1997, pp. 8-8
Authors:
DORAISWAMY PM
BIEBER F
KAISER L
KRISHNAN KR
REUNINGSCHERER J
GULANSKI B
Citation: Pm. Doraiswamy et al., THE ALZHEIMERS-DISEASE ASSESSMENT SCALE - PATTERNS AND PREDICTORS OF BASE-LINE COGNITIVE PERFORMANCE IN MULTICENTER ALZHEIMERS-DISEASE TRIALS, Neurology, 48(6), 1997, pp. 1511-1517
Authors:
CYRUS P
ORAZEM J
RUZICKA B
MAS J
BIEBER F
GULANSKI B
Citation: P. Cyrus et al., METRIFONATE TREATMENT OF ALZHEIMERS-DISEASE (AD) - INFLUENCE OF DEMOGRAPHIC CHARACTERISTICS, Journal of the American Geriatrics Society, 45(9), 1997, pp. 40-40
Authors:
PETTIGREW LC
SMITH CD
SCHMITT FA
WERMELING D
TIKHTMAN AJ
DOSHI N
ASHFORD GW
GULANSKI B
Citation: Lc. Pettigrew et al., CEREBRAL ENERGY-METABOLISM AND COGNITIVE PERFORMANCE IN ALZHEIMERS-DISEASE, Neurology, 44(4), 1994, pp. 10000180-10000180
Risultati:
1-19
|